Dietary Copper Deficiency and Endothelium-Dependent Relaxation of Rat Aorta

Proceedings of the Society for Experimental Biology and Medicine

Volumn 200, Issue 1, 1992, Pages 19-24

  Saari, Jack T ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; COPPER; ENDOTHELIUM DERIVED RELAXING FACTOR; HISTAMINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; AORTA; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER DEFICIENCY; DIET SUPPLEMENTATION; DRUG MECHANISM; ENDOTHELIUM; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ANIMAL; AORTA; COPPER; CYCLIC GMP; ENDOTHELIUM, VASCULAR; IN VITRO; MALE; NITRIC OXIDE; PHENYLEPHRINE; RATS; RATS, INBRED STRAINS; VASODILATION;

EID: 0026547667     PISSN: 00379727     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/00379727-200-43388     Document Type: Article

References (42)

1. Hunsacker HA, Morita M, Allen KGD. Marginal copper deficiency in rats. Aortal morphology of elastin and cholesterol values in first-generation adult males. Atherosclerosis 51:1–19, 1984.
2. Kitano S. Membrane and contractile properties of rat vascular tissue in copper-deficient conditions. Circ Res 46:681–689, 1980.
3. Schuschke DA, Saari JT, Ackermann DM, Miller FN. Microvascular responses in copper-deficient rats. Am J Physiol 257:H1607–H1612, 1989.
4. Johnson WT, Kramer TR. Effect of copper deficiency on erythrocyte membrane proteins of rats. J Nutr 117:1085–1090, 1987.
5. Nielsen FH, Zimmerman TJ, Shuler TR. Interactions among nickel, copper and iron in rats. Liver and plasma contents of lipids and trace elements. Biol Trace Elem Res 4:125–143, 1982.
6. Sunderman FW, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 16:903–910, 1970.
7. Allain CA, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 20:470–475, 1974.
8. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: John Wiley and Sons, 1986.
9. Prohaska JR. Biochemical changes in copper deficiency. J Nutr Biochem 1:452–461, 1990.
10. Klevay LM. The role of copper, zinc, and other chemical elements in ischemic heart disease. In: Rennert OM, Chan W-Y, Eds. Metabolism of Trace Metals in Man. Boca Raton, FL: CRC Press, p 129, 1984.
11. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376, 1980.
12. Davies JM, Williams KI. Endothelial-dependent relaxant effects of vaso-active intestinal polypeptide and arachidonic acid in rat aortic strips. Prostaglandins 27:195–202, 1984.
13. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 52:352–357, 1983.
14. Van de Voorde J, Leusen I. Role of the endothelium in the vasodilator response of rat thoracic aorta to histamine. Eur J Pharmacol 87:113–120, 1983.
15. Carrier GO, White RE, Kirby ML. Histamine-induced relaxation of rat aorta. Importance of H1 receptor and vascular endothelium. Blood Vessels 21:180–183, 1984.
16. Gryglewski RJ, Botting RM, Vane JR. Mediators produced by the endothelial cell. Hypertension 12:530–548, 1988.
17. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor (EDRF) produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265–9269, 1987.
18. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526, 1987.
19. Murad F, Ishii K. Hormonal regulation of the different isoforms of guanylate cyclase: EDRF is a ubiquitous activator of soluble guanylate cyclase. In: Rubanyi GM, Vanhoutte PM, Eds. Endothelium-Derived Relaxing Factors. Basel: Karger, p 151, 1990.
20. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 30:293–331, 1979.
21. Gerzer R, Bohme E, Hofmann F, Schultz G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FERS Lett 132:71–74, 1981.
22. Gubler CJ, Lahey ME, Chase MS, Cartwright GE, Wintrobe MM. Studies on copper metabolism. III. The metabolism of iron in copper deficient swine. Blood 7:1075–1092, 1952.
23. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41:485–490, 1991.
24. Rapoport RM, Murad F. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: Role of cyclic GMP. J Cyclic Nucleotide Protein Phosphor Res 9:281–296, 1983.
25. Rapoport RM, Murad F. Role of cyclic GMP in endothelium-dependent relaxation of vascular smooth muscle. In: Vanhoutte PM, Ed. Relaxing and Contracting Factors. Clifton, NJ: Humana Press, p 219, 1988.
26. Martin W, Furchgott RF, Villani GM, Jothianandan D. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther 237:539–547, 1986.
27. Allen KGD. Copper and the artery. In: Lei KY, Ed. Role of Copper in Lipid Metabolism. Boca Raton, FL: CRC Press, p 201, 1990.
28. Rubanyi GM. Endothelium-derived relaxing and contracting factors. J Cell Biochem 46:27–36, 1991.
29. L'Abbé MR, Fischer PWF. The effects of high dietary zinc and copper deficiency on the activity of copper-requiring metalloenzymes in the growing rat. J Nutr 114:813–822, 1984.
30. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250:H822–H827, 1986.
31. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454–456, 1986.
32. Lüscher TF, Yang Z, Diederich D, Bühler FR. Endothelium-derived vasoactive substances: Potential role in hypertension, atherosclerosis, and vascular occlusion. J Cardiovasc Pharmacol 14:S63–S69, 1989.
33. Wu BN, Medeiros DM, Lin K-N, Thorne BM. Long term effects of dietary copper and sodium upon blood pressure in the Long-Evans rat. Nutr Res 4:305–314, 1984.
34. Fields M, Ferretti RJ, Smith JC, Reiser S. Effect of dietary carbohydrates and copper status on blood pressure of rats. Life Sci 34:763–769, 1984.
35. Medeiros DM. Hypertension in the Wistar-Kyoto rat as a result of post-weaning copper restriction. Nutr Res 7:231–235, 1987.
36. Klevay LM. Hypertension in rats due to copper deficiency. Nutr Rep Int 35:999–1005, 1987.
37. Schuschke DA, Reed MWR, Saari JT, Miller FN. Copper deficiency differentially alters vasodilation in the rat cremaster muscle microcirculation. J Nutr (in press).
38. Schuschke DA, Joshua IG, Miller FN. A comparison of early microcirculatory and aortic changes in hypercholesterolemic rats. Arteriosclerosis Thrombosis 11:154–160, 1991.
39. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 63:903–910, 1988.
40. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 64:900–914, 1989.
41. Jayakody L, Kappagoda T, Senaratne MPJ, Thomson ABR. Impairment of endothelium-dependent relaxation: An early marker for atherosclerosis in the rabbit. Br J Pharmacol 94:335–346. 1988.
42. Browning JD, Reeves PG, O'Dell BL. Zinc deficiency in rats reduces the vasodilation response to bradykinin and prostacyclin. J Nutr 117:490–495, 1987.